A once great department has fallen far - Anonymous employee Merck Employee Review

2.0
Jan 10, 2021
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

-Colleagues are incredibly talented, professional, hard working, and an all around pleasure to work with. -Management understands the importance of work/life balance. -Salary and benefits are solid. -Having "Merck" on your resume will help you throughout your career. -The day-to-day job is fun and rewarding.

Cons

Chemistry management simply does not care about discovering drugs. They treat the department like an academic institution by emphasizing visibility, publications, and external presentations above all else. First line management (Directors) are more or less ineffective. They have too many direct reports, and their seldom interaction with them leads to them being out of touch and disconnected from the lab workers. This further leads to year-end reviews that honestly look like they're just guessing. Promotions are inscrutable. Management refuses to provide any clarity to the process. Playing games and politicking helps, but your work certainly doesn't.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All